Published in Coeur Med Interne on January 25, 1977
Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg (1983) 5.82
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab (2006) 5.78
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg (1992) 3.69
Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg (1980) 2.97
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab (1986) 2.70
Cardiac hemangiomas. Ann Thorac Surg (1993) 2.67
Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol (1986) 2.64
Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer (1998) 2.57
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology (2007) 2.52
Elastase-induced experimental aneurysms in rats. Circulation (1990) 2.50
Endoscopic coronary artery bypass grafting with the aid of robotic assisted instruments. J Thorac Cardiovasc Surg (1999) 2.46
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer (1999) 2.40
A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg (1971) 2.32
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut (2002) 2.31
Cardiac valve papillary fibroelastoma: surgical excision for revealed or potential embolization. J Thorac Cardiovasc Surg (1999) 2.24
Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation (2001) 2.20
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg (2001) 2.16
Acute myocardial infarction: can it be a complication of acute organophosphorus compound poisoning? J Postgrad Med (2013) 2.15
Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10
Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg (1969) 2.04
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. Clin Endocrinol (Oxf) (1998) 1.99
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? J Clin Endocrinol Metab (2000) 1.96
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer (2001) 1.95
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene (1997) 1.91
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res (2001) 1.74
The aorta-to-coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg (1973) 1.71
Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet (2001) 1.68
Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab (1999) 1.67
A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol (1999) 1.67
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys (1996) 1.63
Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. J Thorac Cardiovasc Surg (1996) 1.60
Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant (2011) 1.57
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol (2004) 1.52
The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Eur J Cancer (2004) 1.52
Left ventricular outflow tract obstruction after mitral valve repair. Results of the sliding leaflet technique. Circulation (1993) 1.52
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology (2000) 1.52
Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol (1999) 1.51
The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg (1998) 1.49
Valve repair with Carpentier techniques. The second decade. J Thorac Cardiovasc Surg (1990) 1.49
Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest (1988) 1.48
Comparison of the acute hemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair. Crit Care Med (1999) 1.48
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47
Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits. Atherosclerosis (1999) 1.46
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene (2011) 1.45
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology (2005) 1.44
Peripheral vascular involvement in heart transplant patients. Ann Vasc Surg (1994) 1.43
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res (2000) 1.43
Angiographic and electron-beam computed tomography studies of retrograde cardioplegia via the coronary sinus. J Thorac Cardiovasc Surg (1996) 1.43
Presence of mutations in all three ras genes in human thyroid tumors. Oncogene (1990) 1.42
Congenital malformations of the mitral valve in children. Pathology and surgical treatment. J Thorac Cardiovasc Surg (1976) 1.42
Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) (2010) 1.41
Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface. Cancer Res (1993) 1.41
[Ascending aortic ectasia. New reinforcement technique]. Presse Med (1991) 1.39
[Chronic meningitis before diagnosis of celiac disease]. Rev Neurol (Paris) (2002) 1.39
Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Crit Care Med (1999) 1.39
Early extubation after mitral valve surgery: a target-controlled infusion of propofol and low-dose sufentanil. J Cardiothorac Vasc Anesth (1997) 1.38
Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol (1990) 1.38
Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38
Effects of cardioplegic solutions on the vasoreactivity of the internal mammary artery. Ann Thorac Surg (1998) 1.37
gsp mutations in human thyroid tumours. Oncogene (1991) 1.37
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level. Endocr Relat Cancer (2011) 1.36
Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg (2000) 1.35
RET mutations in exons 13 and 14 of FMTC patients. Oncogene (1995) 1.35
Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg (1974) 1.35
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest (1999) 1.35
Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation (2001) 1.34